Arbutus has moved into Part 3 of this clinical trial which evaluates repeat dosing of AB-101 for 28 days in patients with cHBV and expects to report preliminary data in the first half of next year.

Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14% on an operational basis due to ...

A convicted sex-offender is now going to spend 40 years in prison after murdering a 2-year-old girl and threatening the ...

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.

Starbucks is getting ready for the holiday season by bringing back Reusable Red Cup Giveaway Day on Thursday. On Thursday, Nov. 14, customers will be able to receive a free limited-edition reusable ...